Compounded Medicine
The quiet, unglamorous layer of the market that most patients are actually on.
Compounded medications sit in the structural seam between the branded pharmaceutical market and the out-of-pocket telehealth economy. This desk follows the FDA enforcement, the 503A/503B distinction, the pricing, and the quality questions that most patients never think to ask.
This Week's Feature
Hand-picked by the desk.
Compounded GLP-1s, Explained Without the Spin
The FDA shortage exemption, the 503A/503B distinction, the patent landscape — everything patients ask their doctor about, rendered without the telehealth-marketing gloss or the pharma-lobbyist scare story.
Read the feature →